ON AUGUST 16,
2007 (WITH CREDIT GIVEN FOR ALL AMOUNTS PAID BY NOVARX UNDER THIS SECTION 3).
4.
IRC HEREBY REPRESENTS AND WARRANTS
THAT:
(A)
IRC HOLDS NO WARRANTS FOR THE PURCHASE OF
THE STOCK OF EITHER NOVARX OR ABI; AND
(B)
IRC HAS GRANTED NO SUBLICENSES OF THE RIGHTS
GRANTED TO IRC IN THE LICENSE AGREEMENT BETWEEN SKCC AND IRC (AS DEFINED IN THE
SKCC NOVATION AGREEMENT) OTHER THAN TO NOVARX AND ABI.
5.
THE FRAMEWORK AGREEMENT AND THE OTHER
WRITTEN AGREEMENTS SPECIFIED HEREIN CONSTITUTE THE ENTIRE AGREEMENT BETWEEN AND
AMONG THE PARTIES WITH REGARD TO THE SUBJECT MATTER HEREOF AND THEREOF, AND
SUPERSEDE ALL PRIOR AND CONTEMPORANEOUS AGREEMENTS, COMMITMENTS AND DISCUSSIONS
WITH REGARD TO SUCH SUBJECT MATTER.
THIS AGREEMENT CAN BE AMENDED ONLY IN A
WRITING SIGNED BY THE PARTIES HERETO.
THE IMMUNE RESPONSE CORPORATION
By:
NOVARX CORPORATION
By:
2